Product correctly added to cart.

discount label
Eslicarbazepine Acetate
View 3D

Targetmol logo

Eslicarbazepine Acetate

CAS: 236395-14-5

Ref. TM-T3285

5mg
38.00 €
10mg
50.00 €
25mg
90.00 €
50mg
122.00 €
100mg
167.00 €
200mg
263.00 €
500mg
385.00 €
1ml*10 (DMSO)
54.00 €
Estimated delivery in United States, on Friday 17 May 2024

Product Information

Name:
Eslicarbazepine Acetate
Synonyms:
  • Zebinix, Aptiom, BIA 2-093, Exalief, Stedesa
  • (10S)-10-(Acetyloxy)-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide
  • (S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide
  • (S)-(-)-10-Acetoxy-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide
  • (S)-5-Carbamoyl-10,11-dihydro-5H-dibenzo[b,f]azepin-10-yl acetate
  • 5H-Dibenz[b,f]azepine-5-carboxamide, 10-(acetyloxy)-10,11-dihydro-, (10S)-
  • Aptiom
  • Bia 2-093
  • Exalief
  • Exelief
  • See more synonyms
  • Sep 0002093
  • Zebinix
Description:

Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.

Brand:
Targetmol
Long term storage:
Notes:

Chemical properties

Molecular weight:
296.32
Formula:
C17H16N2O3
Purity:
100%
Color/Form:
White To Off-White Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TM-T3285 Eslicarbazepine Acetate

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".